Alligator Bioscience AB enters into drug development collaboration with major European pharmaceutical company
According to the agreement Alligator Bioscience will receive milestone payments for the development as well as milestone payments during the clinical development of the final product.
Commenting on the agreement, Gun-Britt Fransson, CEO of Alligator Bioscience, says "We are very pleased to have entered this agreement and started to build a trustful relation with our partner. This enables us to furthermore build and explore the efficiency and uniqueness of the FINDTM technology while providing our customer with improved versions of the therapeutic protein".
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.